Abstract
The American Thoracic Society/European Respiratory Society jointly created a Task Force on "Outcomes for COPD pharmacological trials: from lung function to biomarkers" to inform the chronic obstructive pulmonary disease research community about the possible use and limitations of current outcomes and markers when evaluating the impact of a pharmacological therapy. Based on their review of the published literature, the following document has been prepared with individual sections that address specific outcomes and markers, and a final section that summarises their recommendations.
Original language | English |
---|---|
Pages (from-to) | 416-69 |
Journal | European Respiratory Journal |
Volume | 31 |
Issue number | 2 |
DOIs | |
Publication status | Published - 1 Jan 2008 |